Literature DB >> 18729722

X chromosome dosage compensation: how mammals keep the balance.

Bernhard Payer1, Jeannie T Lee.   

Abstract

The development of genetic sex determination and cytologically distinct sex chromosomes leads to the potential problem of gene dosage imbalances between autosomes and sex chromosomes and also between males and females. To circumvent these imbalances, mammals have developed an elaborate system of dosage compensation that includes both upregulation and repression of the X chromosome. Recent advances have provided insights into the evolutionary history of how both the imprinted and random forms of X chromosome inactivation have come about. Furthermore, our understanding of the epigenetic switch at the X-inactivation center and the molecular aspects of chromosome-wide silencing has greatly improved recently. Here, we review various facets of the ever-expanding field of mammalian dosage compensation and discuss its evolutionary, developmental, and mechanistic components.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729722     DOI: 10.1146/annurev.genet.42.110807.091711

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  253 in total

Review 1.  Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control.

Authors:  Jeannie T Lee
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

2.  Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles.

Authors:  Ryu Miyagawa; Keiko Tano; Rie Mizuno; Yo Nakamura; Kenichi Ijiri; Randeep Rakwal; Junko Shibato; Yoshinori Masuo; Akila Mayeda; Tetsuro Hirose; Nobuyoshi Akimitsu
Journal:  RNA       Date:  2012-02-21       Impact factor: 4.942

3.  Genomic imprinting and epigenetic control of development.

Authors:  Andrew Fedoriw; Joshua Mugford; Terry Magnuson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

4.  Expression reduction in mammalian X chromosome evolution refutes Ohno's hypothesis of dosage compensation.

Authors:  Fangqin Lin; Ke Xing; Jianzhi Zhang; Xionglei He
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 5.  The X as model for RNA's niche in epigenomic regulation.

Authors:  Jeannie T Lee
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

6.  Two-step imprinted X inactivation: repeat versus genic silencing in the mouse.

Authors:  Satoshi H Namekawa; Bernhard Payer; Khanh D Huynh; Rudolf Jaenisch; Jeannie T Lee
Journal:  Mol Cell Biol       Date:  2010-04-19       Impact factor: 4.272

7.  Strong purifying selection at genes escaping X chromosome inactivation.

Authors:  Chungoo Park; Laura Carrel; Kateryna D Makova
Journal:  Mol Biol Evol       Date:  2010-06-09       Impact factor: 16.240

Review 8.  DNA replication timing, genome stability and cancer: late and/or delayed DNA replication timing is associated with increased genomic instability.

Authors:  Nathan Donley; Mathew J Thayer
Journal:  Semin Cancer Biol       Date:  2013-01-14       Impact factor: 15.707

Review 9.  Searching for naïve human pluripotent stem cells.

Authors:  Simone Aparecida Siqueira Fonseca; Roberta Montero Costas; Lygia Veiga Pereira
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

10.  Quick fluorescent in situ hybridization protocol for Xist RNA combined with immunofluorescence of histone modification in X-chromosome inactivation.

Authors:  Minghui Yue; John Lalith Charles Richard; Norishige Yamada; Akiyo Ogawa; Yuya Ogawa
Journal:  J Vis Exp       Date:  2014-11-26       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.